Correlation Between Monte Rosa and PureTech Health
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and PureTech Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and PureTech Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and PureTech Health PLC, you can compare the effects of market volatilities on Monte Rosa and PureTech Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of PureTech Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and PureTech Health.
Diversification Opportunities for Monte Rosa and PureTech Health
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Monte and PureTech is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and PureTech Health PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PureTech Health PLC and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with PureTech Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PureTech Health PLC has no effect on the direction of Monte Rosa i.e., Monte Rosa and PureTech Health go up and down completely randomly.
Pair Corralation between Monte Rosa and PureTech Health
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 1.88 times more return on investment than PureTech Health. However, Monte Rosa is 1.88 times more volatile than PureTech Health PLC. It trades about 0.02 of its potential returns per unit of risk. PureTech Health PLC is currently generating about -0.01 per unit of risk. If you would invest 713.00 in Monte Rosa Therapeutics on October 24, 2024 and sell it today you would lose (160.00) from holding Monte Rosa Therapeutics or give up 22.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. PureTech Health PLC
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| PureTech Health PLC |
Monte Rosa and PureTech Health Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and PureTech Health
The main advantage of trading using opposite Monte Rosa and PureTech Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, PureTech Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PureTech Health will offset losses from the drop in PureTech Health's long position.| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
| PureTech Health vs. Molecular Partners AG | PureTech Health vs. MediciNova | PureTech Health vs. Anebulo Pharmaceuticals | PureTech Health vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |